Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Capital Expenditures (2019 - 2025)

Historic Capital Expenditures for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $89000.0.

  • Pulmonx's Capital Expenditures fell 7860.58% to $89000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $550000.0, marking a year-over-year decrease of 6419.27%. This contributed to the annual value of $1.4 million for FY2024, which is 7930.61% up from last year.
  • As of Q3 2025, Pulmonx's Capital Expenditures stood at $89000.0, which was down 7860.58% from $49000.0 recorded in Q2 2025.
  • In the past 5 years, Pulmonx's Capital Expenditures registered a high of $1.6 million during Q3 2021, and its lowest value of -$19000.0 during Q2 2023.
  • Over the past 5 years, Pulmonx's median Capital Expenditures value was $299000.0 (recorded in 2022), while the average stood at $404315.8.
  • In the last 5 years, Pulmonx's Capital Expenditures plummeted by 10635.45% in 2023 and then skyrocketed by 256842.11% in 2024.
  • Pulmonx's Capital Expenditures (Quarter) stood at $1.1 million in 2021, then plummeted by 84.67% to $176000.0 in 2022, then rose by 13.64% to $200000.0 in 2023, then tumbled by 44.5% to $111000.0 in 2024, then decreased by 19.82% to $89000.0 in 2025.
  • Its Capital Expenditures was $89000.0 in Q3 2025, compared to $49000.0 in Q2 2025 and $301000.0 in Q1 2025.